Literature DB >> 11139256

Novel mutations in the GALK1 gene in patients with galactokinase deficiency.

M Hunter1, D Angelicheva, H L Levy, S M Pueschel, L Kalaydjieva.   

Abstract

Galactokinase deficiency is an inborn error of galactose metabolism whose major clinical manifestation is the development of cataracts during the first months of life. Only 20 mutations have been reported to date and understanding of the functionally important domains of the galactokinase protein is still limited. Here we report four novel mutations in GALK1 that were identified in two unrelated patients with galactokinase deficiency. Three of these were amino acid substitutions: 1569C-->T in exon 2 (R68C); 7093C-->T in exon 6 (T288M) and 7538G-->C in exon 8 (A384P). In addition, a single base-pair deletion was found in exon 5 (2833delC), predicted to result in a shift of the reading frame and a premature termination codon at position 263. Some differences with the GALK1 sequence deposited in Genbank are also reported. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139256     DOI: 10.1002/1098-1004(2001)17:1<77::AID-HUMU20>3.0.CO;2-H

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

Review 1.  Inherited Congenital Cataract: A Guide to Suspect the Genetic Etiology in the Cataract Genesis.

Authors:  Olga Messina-Baas; Sergio A Cuevas-Covarrubias
Journal:  Mol Syndromol       Date:  2017-02-07

Review 2.  Clinical features of galactokinase deficiency: a review of the literature.

Authors:  A M Bosch; H D Bakker; A H van Gennip; J V van Kempen; R J A Wanders; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2002-12       Impact factor: 4.982

3.  Features and outcome of galactokinase deficiency in children diagnosed by newborn screening.

Authors:  Julia B Hennermann; Peter Schadewaldt; Barbara Vetter; Yoon S Shin; Eberhard Mönch; Jeannette Klein
Journal:  J Inherit Metab Dis       Date:  2011-02-03       Impact factor: 4.982

4.  Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors.

Authors:  Li Liu; Manshu Tang; Rajan Pragani; Frank G Whitby; Ya-Qin Zhang; Bijina Balakrishnan; Yuhong Fang; Surendra Karavadhi; Dingyin Tao; Christopher A LeClair; Matthew D Hall; Juan J Marugan; Matthew Boxer; Min Shen; Christopher P Hill; Kent Lai; Samarjit Patnaik
Journal:  J Med Chem       Date:  2021-09-07       Impact factor: 7.446

5.  Comparative modeling and genomics for galactokinase (Gal1p) enzyme.

Authors:  Ashwani Sharma; Pushkar Malakar
Journal:  Bioinformation       Date:  2011-02-15

6.  A novel c.-22T>C mutation in GALK1 promoter is associated with elevated galactokinase phenotype.

Authors:  Hyung-Doo Park; Yoon-Kyoung Kim; Kyoung Un Park; Jin Q Kim; Young-Han Song; Junghan Song
Journal:  BMC Med Genet       Date:  2009-03-24       Impact factor: 2.103

7.  Panel-based targeted exome sequencing reveals novel candidate susceptibility loci for age-related cataracts in Chinese Cohort.

Authors:  Jian-Kang Li; Li-Li Li; Wei Li; Zi-Wei Wang; Feng-Juan Gao; Fang-Yuan Hu; Sheng-Hai Zhang; Shou-Fang Qu; Jie Huang; Lu-Sheng Wang; Ji-Hong Wu; Fang Chen
Journal:  Mol Genet Genomic Med       Date:  2020-04-26       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.